X Close
Learn more about OnePulse connect for healthcare practices
SCHEDULE A DEMO
Learn how we can advance patient outcomes with innovative technology solutions
SCHEDULE A CONSULTATIVE MEETING
Learn more about OnePulse connect for healthcare practices
Learn how we can advance patient outcomes with innovative technology solutions
Intravenous immunoglobulin (IVIG) therapy has become increasingly central to specialty practices treating immunodeficiency, autoimmune, and neurological conditions. While these therapies offer transformative benefits for patients, they present significant operational challenges that can overwhelm even well-resourced practices.
The complexity stems from multiple factors: infusion durations ranging from 2 to 6 hours, individualized pre-medication protocols, stringent monitoring requirements, and the critical need to manage potential infusion reactions, all while maintaining efficient chair utilization and practice profitability.
According to a comprehensive cross-institutional protocol review, "Administering IVIG requires careful attention to dosing, infusion rates, pre-medications, and reaction management, as variability in these factors can significantly impact patient safety" (Payne et al., 2025). Maximum infusion rates vary widely across institutions from 2.4 to 8 mL/kg/hr, highlighting the lack of standardization that complicates scheduling and staffing.
The administrative burden extends far beyond the infusion itself. A 2023 quality improvement study found that "it can still be difficult for patients to receive timely access to therapies given the administrative burden, including the need to complete a manual review process" for prior authorizations (Seifert et al., 2023). Practices must navigate complex insurance requirements, manage inventory for high-cost medications, and maintain compliance with evolving regulations. Ensuring optimal patient care becomes challenging in the face of these circumstances.
Managing infusion services involves far more than supervising IV drips and monitoring patients. The operational reality is that "infusion nurses are involved in communications, education, medication administration, and documentation, and they are often rapidly shifting between tasks or multitasking" throughout their shifts (Zhao et al., 2025). This constant behind-the-scenes activity means that traditional metrics like chair utilization, which may show active treatment occurring only a fraction of the time, fail to capture the true resource intensity of infusion programs.
Practices often discover too late that the staffing, training, and administrative requirements far exceed initial projections.
Infusion reactions, occurring in approximately 5% of IVIG infusions (Palabrica et al., 2013), can double scheduled chair time and create cascading delays throughout the day. Managing these disruptions requires experienced staff who can quickly assess, intervene, and adjust schedules. This expertise takes years to develop.
Research demonstrates that office-based infusion settings achieve superior adherence rates compared to hospital or home settings. A study found that 79.3% of office-based patients remained on treatment by day 200, compared to only 64.4% for home-based infusions (Giese-Kim et al., 2020). However, achieving these outcomes requires operational efficiency that many practices struggle to maintain independently.
Given these complexities, many specialty practices are discovering that partnering with infusion management experts provides the optimal solution. Rather than attempting to build and maintain infusion capabilities in-house, strategic outsourcing allows practices to:
OnePulse Connect - Infusion provides a complete turnkey solution that manages all aspects of IVIG and specialty infusion programs from inception through ongoing operations. Our comprehensive approach includes:
By partnering with OnePulse Connect - Infusion, practices can offer state-of-the-art infusion services without operational complexity, allowing them to focus on what they do best, caring for patients.
The management of IVIG and complex infusion therapies represents both an opportunity and a challenge for specialty practices. While these services are essential for patient care and can enhance practice revenue, the operational complexity often exceeds what practices can efficiently manage independently.
Partnering with OnePulse Connect - Infusion provides the expertise, infrastructure, and support necessary to deliver exceptional infusion services while eliminating operational burden. In today's healthcare environment, this strategic approach represents not just an option, but an essential strategy for practices committed to providing comprehensive, high-quality care.
Learn More about your turnkey In-Office Infusion program here.
Elevate Health Technologies is committed to making healthcare better for everyone. We collaborate with healthcare providers, patients, pharmaceutical manufacturers, and payors to deliver innovative technologies that truly make a difference. OnePulse Connect empowers healthcare practices by optimizing efficiency and streamlining care, whether through buy-and-bill management, inventory tracking, medically integrated dispensing, or in-office infusion services. Our tailored approach delivers deep data insights, advanced analytics, and dynamic patient engagement platforms. Together, we move as One Pulse, driving smarter, faster, and more connected health technologies for improved outcomes and better patient experiences.
Visit www.elevateht.com to learn more.
Be sure to follow us on LinkedIn!
References
Copyright © 2025 Elevate Health Technologies
